M&A Deal Summary

InoLife Technologies Acquires STEMTIDE

On July 14, 2011, InoLife Technologies acquired life science company STEMTIDE

Acquisition Highlights
  • This is InoLife Technologies’ 1st transaction in the Life Science sector.
  • This is InoLife Technologies’ 1st transaction in the United States.
  • This is InoLife Technologies’ 1st transaction in Texas.

M&A Deal Summary

Date 2011-07-14
Target STEMTIDE
Sector Life Science
Buyer(s) InoLife Technologies
Deal Type Add-on Acquisition

Target

STEMTIDE

Houston, Texas, United States
STEMTIDE, Inc. is a biotechnology company with manufacturing and marketing rights to the age reversing products which are chemical free formulas for activation of endogenous "stem cells" in the skin and body, formulated exclusively from all natural ingredients.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

InoLife Technologies

Raleigh, North Carolina, United States

Category Company
Sector Life Science
Employees6
DESCRIPTION

InoLife Technologies, Inc. is a organized to develop and market DNA Testing products within the US. The Company's mission is to aggressively identify, manufacture and market innovative and affordable healthcare products and services directly to the marketplace.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2011 M&A 1 of 1